Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
Date:3/3/2010

U.S.$) 2009 2008 2009 2008 ------------------------------------------------------------------------- GAAP net loss $ (15,633) $ (76,963) $ (22,868) $ (741,176) Interest expense on long-term debt 9,068 10,639 38,039 44,490 Income tax expense (recovery) (1,532) (2,577) 6,037 (12,892) Depreciation and Amortization 9,460 9,327 37,026 38,174 ------------------------------------------------------------------------- EBITDA 1,363 (59,574) 58,234 (671,404) Adjustments: Non-recurring revenue, net of license fees(a) (53) (352) (25,556) (910) Restructuring related charges(b) (309) 1,583 3,820 10,407 In-process and non-recurring research and development charges(c) 500 313 1,866 3,438 Non-recurring supply/distribution agreement termination costs(b) - - - 500 Stock-based compensation(d) 408 458 1,579 2,439 Litigation expenses(g) 684 177 3,297 2,670 Foreign exchange loss (gain)(h) 385 1,032 1,612 (540) Investment and other income 196 498 122 (1,255) Write-downs of investments and other long-lived assets(i) 3,090 12,247 3,090 24,870 Write-down of goodwill(i) - 50,285 - 649,685 Write-downs and other non-recurring deferred financing costs(f) - 3,665 643 17,209 Non-recurring char
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Angiotech Pharmaceuticals Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
3. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
4. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
5. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
9. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
10. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... Sleep disturbances such as insomnia, hypersomnia, ... depression. According to a study published by the ... of depressed patients have insomnia symptoms, and hypersomnia ... adults and 10% of older patients, with a ... have a major impact on quality of life, ...
(Date:7/18/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... operating officer and president, has resigned, effective July 31, ... consultant going forward on special projects. His resignation is ... this position since September 2013. On an interim basis, ... , who has been Neogen,s chief executive officer since ...
(Date:7/18/2014)... 18, 2014 Global biotechnology company ... offices in Cambridge, MA, announces the launch of ... Software product that leverages the power of Next ... MiSeq sequencing platform. The assay and software have ... of Philadelphia (CHOP) and will include a new ...
(Date:7/18/2014)... MA (PRWEB) July 18, 2014 Provia ... to its growing Advisory Board. Dr. Vaught has ... for over 20 years. As one of the ... Biological and Environmental Repositories - in 1999, he served ... is again president-elect. , In 2005, Dr. Vaught began ...
Breaking Biology Technology:Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 3Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 2Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 3
... TORONTO, Sept. 20 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc.,(TSX:SDI) ... Endotoxin,Activity Assay, a rapid diagnostic product for sepsis, ... division of the Italian,Menarini Group. Sepsis is the ... 60,000 victims each year. The treatment of severe ...
... Zentaris Inc.,(TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company ... President and CEO,David J. Mazzo, Ph.D., will present a ... Thursday, September 27, 2007 at 10:00 a.m.,Eastern, in the ... York City. A live webcast of this presentation ...
... Sept. 20 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ... commercializing proprietary product candidates for the treatment,of cancer ... Levine,ADVENTRX,s chief executive officer, is scheduled to present ... September 27th, 2007 at 8:00 a.m.,Eastern Time. The ...
Cached Biology Technology:Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany 2ADVENTRX Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference 2
(Date:7/21/2014)... there are reasons mammoths and mastodons could have been ... research from the University of Cincinnati, the famously fuzzy ... before it was trendy at the end of ... Crowley, an assistant professor of geology and anthropology, shows ... likely were year-round residents and not nomadic migrants as ...
(Date:7/21/2014)... water and save on your utility bill? A paper ... the current issue of the journal Environment ... Effective Actions U.S. Households Can Take to Curb Water ... by simple actions such as installing more efficient appliances ... suggestions may be familiar, the researchers are the first ...
(Date:7/21/2014)... Medicine-led study suggests that parents of obese children often ... childhood weight gain or the importance of daily physical ... , The study is published online in the ... , "Parents have a hard time changing their child,s ... Rhee, MD, and an assistant adjunct professor in the ...
Breaking Biology News(10 mins):Mammoth and mastodon behavior was less roam, more stay at home 2Mammoth and mastodon behavior was less roam, more stay at home 3Researchers provide guide to household water conservation 2Researchers provide guide to household water conservation 3Parents rank their obese children as 'very healthy' 2
... Homeland Security announced the creation of five new ... Centers will study border security and immigration; explosives ... security; natural disasters, coastal infrastructure and emergency management; ... Center for Southeastern Tropical Advanced Remote Sensing (CSTARS) ...
... production must increase by more than 10 percent each ... energy demands and replace fossil fuels, but this is ... Inderscience,s International Journal of Nuclear Governance, Economy and Ecology ... improvement in nuclear power efficiency otherwise each new power ...
... dietary supplement called NutraStem has been shown to ... product, NutraStem also known as NT-020, is a ... carnosine extracts- a combination of nutritional ingredients thought to ... is the third leading cause of death and the ...
Cached Biology News:CSTARS to form part of Department of Homeland Security's Center of Excellence for Maritime Security 2Nuclear cannibals 2Blueberry and green tea containing supplement protects against stroke damage 2
Guanylate Kinase Purified Anti-Mouse, Anti-Rat clone 28, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
... H2OBIT is a fully licensed, high throughput, water ... of up to 24 microplates. This equates to ... ,A robotic arm rapidly transfers a basket ... temperature ramping times that are considerably faster than ...
... used gasketed gel trays. Turn the tray 90 degrees ... back and run the gel - its as simple ... tray is UV transparent. Each tray accommodates two comb ... one in the center. This allows you the option ...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
Biology Products: